Resveratrol and cancer: Challenges for clinical translation.
Resveratrol and cancer: Challenges for clinical translation.
复制标题
DOI:
10.1016/j.bbadis.2014.11.004
复制
发表时间:
2015-06
影响因子:
6.2
通讯作者:
Ahmad, Nihal
中科院分区:
文献类型:
--
作者:
Singh, Chandra K.;Ndiaye, Mary A.;Ahmad, Nihal
Significant work has been done towards identifying the health-beneficial effects of the grape antioxidant resveratrol in a variety of bioassay- and disease- models, with much research being focused on its possible application to cancer management. Despite the large number of preclinical studies dealing with different aspects of the biological effects of resveratrol, it’s translation to clinics is far from reality due to a variety of challenges. In this review, we discuss the issues and questions associated with resveratrol becoming an effective in vivo anticancer drug, from basic metabolic issues to the problems faced by incomplete understanding of the mechanism(s) of action in the body. We also explore efforts taken by researchers, both public and private, to contend with some of these issues. By examining the published data and previous clinical trials, we have attempted to identify the problems and issues that hinder the clinical translation of resveratrol for cancer management.
登录
查看更多内容
影响因子:
7.3
作者:
Hoshino J;Park EJ;Kondratyuk TP;Marler L;Pezzuto JM;van Breemen RB;Mo S;Li Y;Cushman M
通讯作者:
Cushman M
DOI:
10.1042/bj20091857
发表时间:
2010-07-15
期刊:
The Biochemical journal
影响因子:
--
作者:
Calamini B;Ratia K;Malkowski MG;Cuendet M;Pezzuto JM;Santarsiero BD;Mesecar AD
通讯作者:
Mesecar AD
影响因子:
5.8
作者:
Kunnimalaiyaan, Muthusamy;Chen, Herbert
通讯作者:
Chen, Herbert
DOI:
10.1111/j.1749-6632.2010.05851.x
发表时间:
2011-01-01
期刊:
RESVERATROL AND HEALTH
影响因子:
--
作者:
Ndiaye, Mary;Kumar, Raj;Ahmad, Nihal
通讯作者:
Ahmad, Nihal
影响因子:
3.6
作者:
Huang, Wu;Chen, Zhuoyou;Pan, Jianchun
通讯作者:
Pan, Jianchun